Evidence map›Paper›PMID 29853783›Full record

ArticleMediators of inflammation2018

A Sustained Reduction in Serum Cholinesterase Enzyme Activity Predicts Patient Outcome following Sepsis.

Aleksandar R Zivkovic, Sebastian O Decker, Anne C Zirnstein, Annette Sigl, Karsten Schmidt, Markus A Weigand, Stefan Hofer, Thorsten Brenner

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Article
  16. Article
  17. Emerging significance of butyrylcholinesterase.World journal of experimental medicine · 2024
    Review
  18. Cholinesterase activities and sepsis-associated encephalopathy in viral versus nonviral sepsis.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2024
    Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Aleksandar R ZivkovicDepartment of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0001-6813-5401
Sebastian O DeckerDepartment of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-3525-1155
Anne C ZirnsteinDepartment of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.
Annette SiglDepartment of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-7697-6785
Karsten SchmidtDepartment of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.
Markus A WeigandDepartment of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.
Stefan HoferDepartment of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.
Thorsten BrennerDepartment of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-4570-877X
Heidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early sepsis identification is of paramount importance for an effective therapy and the patient outcome; however, a suitable prognostic biomarker is lacking. Anti-inflammatory nonneuronal cholinergic signaling modulates the magnitude of an immune response. Serum cholinesterase (BChE), an enzyme that hydrolyzes acetylcholine, plays an important role during inflammatory response and serves as an accurate index of cholinergic activity. BChE activity was measured in septic patients using a point-of-care system, and levels of conventional inflammatory markers and the disease severity scores were obtained. We observed a strong, sustained reduction in BChE activity in patients who died within a 90-day observation period, as compared to survivors. Reduced BChE activity when measured at the ICU admission effectively differentiated between the 90-day survivor and the nonsurvivor patient groups. We estimated a critical BChE level of 1.661 kU/L (CI 0.5-0.8, 94% sensitivity, 48% specificity, AUC 0.7) to best predict patient outcome providing a benchmark criterion for early detection of potentially fatal sepsis measured at the admission. This finding suggests that the BChE activity, used in combination with the laboratory tests, clinical examination, and the disease severity scoring, could serve to identify high-risk patients at the ICU admission, the most critical time point in the sepsis treatment.

Indexed as

AgedBiomarkersCholinesterasesFemaleHumansIntensive Care UnitsKaplan-Meier EstimateMaleMiddle AgedProspective StudiesSepsisBiomarkersCholinesterases

Identifiers

PMID29853783
PMCPMC5949165
OpenAlexW2802002885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.